Ignite Creation Date:
2025-12-25 @ 2:11 AM
Ignite Modification Date:
2025-12-27 @ 1:32 PM
Study NCT ID:
NCT00741260
Status:
COMPLETED
Last Update Posted:
2018-09-05
First Post:
2008-08-22
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study Evaluating The Combination Of Neratinib And Capecitabine In Solid Tumors And Breast Cancer
Sponsor:
Puma Biotechnology, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2008-12-09
Start Date Type:
ACTUAL
Primary Completion Date:
2010-11
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-06
Completion Date Type:
ACTUAL
First Submit Date:
2008-08-22
First Submit QC Date:
None
Study First Post Date:
2008-08-26
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2017-08-10
Results First Submit QC Date:
None
Results First Post Date:
2017-11-09
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2013-01-30
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2018-08-07
Last Update Post Date:
2018-09-05
Last Update Post Date Type:
ACTUAL